Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Medicare targets 15 more drugs for price negotiations
Medicare drug price negotiations to target Ozempic, Wegovy and other drugs
The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden administration announced Friday.
Latest Medicare price drug negotiations includes Ozempic, Wegovy
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services confirmed Friday.
1d
on MSN
Biden commutes sentences for nearly 2,500 non-violent drug offenders convicted on crack cocaine-related charges
President Joe Biden is granting clemency for nearly 2,500 non-violent drug offenders in the final days in office, placing a ...
2d
Outgoing FDA chief flags online weight loss drug dangers
Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...
2d
What Foods Will Be Impacted by FDA’s Ban on Red Dye No. 3—And What Could Replace It
T he U.S. Food and Drug Administration (FDA) banned the use of Red Dye No. 3 in food and ingested drugs on Wednesday, more ...
3d
on MSN
Medicare's new $2,000 cap on out-of-pocket drug costs could save enrollees thousands, AARP says
The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid ...
4d
on MSN
Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
2d
on MSN
Drug-eating rats invade Houston police evidence room, potentially disrupting hundreds of cases
The rodents are enjoying marijuana at the Houston Police Department that has been sitting in evidence for years.
3d
FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
BioPharma Dive
2d
JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson
AbbVie's CEO hinted his company may be less willing to invest in psychiatry after a costly setback, while Lilly explained ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback